Evidence map›Paper›PMID 26541406›Full record

Observational studyJournal of translational medicine2015

HALT & REVERSE: Hsf1 activators lower cardiomyocyt damage; towards a novel approach to REVERSE atrial fibrillation.

Eva A H Lanters, Denise M S van Marion, Charles Kik, Herman Steen, Ad J J C Bogers, Maurits A Allessie, Bianca J J M Brundel, Natasja M S de Groot

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Journal of translational medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 42 citations in OpenAlex.

  1. Trial
  2. Men and women's hearts don't beat the same: Epicardial mapping of Bachmann's bundle.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2025
    Article
  3. How sex affects the sinus rhythm heartbeat.International journal of cardiology. Heart & vasculature · 2023
    Article
  4. Article
  5. Characterization of unipolar electrogram morphology: a novel tool for quantifying conduction inhomogeneity.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Article
  6. Atrial extrasystoles enhance low-voltage fractionation electrograms in patients with atrial fibrillation.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Article
  7. Mapping-guided atrial lead placement determines optimal conduction across Bachmann's bundle: a rationale for patient-tailored pacing therapy.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Identification of local atrial conduction heterogeneities using high-density conduction velocity estimation.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2021
    Article
  14. Article
  15. Article
  16. Sinus rhythm voltage fingerprinting in patients with mitral valve disease using a high-density epicardial mapping approach.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2021
    Article
  17. Review
  18. Article
  19. The Impact of Filter Settings on Morphology of Unipolar Fibrillation Potentials.Journal of cardiovascular translational research · 2020
    Observational
  20. Classification of sinus rhythm single potential morphology in patients with mitral valve disease.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Eva A H LantersDepartment of Cardiology, Ba 579, Erasmus Medical Center, 's Gravendijkwal 230, 3015, CE, Rotterdam, The Netherlands. e.lanters@erasmusmc.nl.
Denise M S van MarionDepartment of Clinical Pharmacy and Pharmacology, EB71, University Institute for Drug Exploration (GUIDE), University Medical Center Groningen, University of Groningen, Hanzeplein 1, PO Box 30 001, 9700, RB, Groningen, The Netherlands. d.m.s.van.marion@umcg.nl.
Charles KikDepartment of Cardiothoracic Surgery, Bd 557, Erasmus Medical Center, 's Gravendijkwal 230, 3015, CE, Rotterdam, The Netherlands. c.kik@erasmusc.nl.
Herman SteenNyken Therapeutics B.V., L.J. Zielstraweg 2, 9713, GX, Groningen, The Netherlands. hermansteen@nyken.com.
Ad J J C BogersDepartment of Cardiothoracic Surgery, Bd 557, Erasmus Medical Center, 's Gravendijkwal 230, 3015, CE, Rotterdam, The Netherlands. a.j.j.c.bogers@erasmusmc.nl.
Maurits A AllessieDepartment of Cardiology, Ba 579, Erasmus Medical Center, 's Gravendijkwal 230, 3015, CE, Rotterdam, The Netherlands. m.allessie@maastrichtuniversity.nl.
Bianca J J M BrundelDepartment of Clinical Pharmacy and Pharmacology, EB71, University Institute for Drug Exploration (GUIDE), University Medical Center Groningen, University of Groningen, Hanzeplein 1, PO Box 30 001, 9700, RB, Groningen, The Netherlands. b.j.j.m.brundel@umcg.nl.
Natasja M S de GrootDepartment of Cardiology, Ba 579, Erasmus Medical Center, 's Gravendijkwal 230, 3015, CE, Rotterdam, The Netherlands. n.m.s.degroot@erasmusmc.nl.
Erasmus MC · NLUniversity Medical Center Groningen · NLUniversity of Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAtrial fibrillation is a progressive arrhythmia, the exact mechanism underlying the progressive nature of recurrent AF episodes is still unknown. Recently, it was found that key players of the protein quality control system of the cardiomyocyte, i.e. Heat Shock Proteins, protect against atrial fibrillation progression by attenuating atrial electrical and structural remodeling (electropathology). HALT & REVERSE aims to investigate the correlation between electropathology, as defined by endo- or epicardial mapping, Heat Shock Protein levels and development or recurrence of atrial fibrillation following pulmonary vein isolation, or electrical cardioversion or cardiothoracic surgery. STUDY

designThis study is a prospective observational study. Three separate study groups are defined: (1) cardiothoracic surgery, (2) pulmonary vein isolation and (3) electrical cardioversion. An intra-operative high-resolution epicardial (group 1) or endocardial (group 2) mapping procedure of the atria is performed to study atrial electropathology. Blood samples for Heat Shock Protein determination are obtained at baseline and during the follow-up period at 3 months (group 2), 6 months (groups 1 and 2) and 1 year (group 1 and 2). Tissue samples of the right and left atrial appendages in patients in group 1 are analysed for Heat Shock Protein levels and for tissue characteristics. Early post procedural atrial fibrillation is detected by continuous rhythm monitoring, whereas late post procedural atrial fibrillation is documented by either electrocardiogram or 24-h Holter registration.

conclusionHALT & REVERSE aims to identify the correlation between Heat Shock Protein levels and degree of electropathology. The study outcome will contribute to novel diagnostic tools for the early recognition of clinical atrial fibrillation. TRIAL REGISTRATIONS: Rotterdam Medical Ethical Committee MEC-2014-393, Dutch Trial Registration NTR4658.

Indexed as

AdolescentAdultAgedAtrial FibrillationCardiopulmonary BypassDNA-Binding ProteinsElectrocardiographyFemaleHeart AtriaHeat Shock Transcription FactorsHumansIntraoperative PeriodMaleMiddle AgedMyocytes, CardiacPericardiumDNA-Binding ProteinsHeat Shock Transcription FactorsHSF1 protein, humanTranscription Factors

Identifiers

PMID26541406
PMCPMC4635598
OpenAlexW2116081472

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.